PLASBUMIN- albumin (human) solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

plasbumin- albumin (human) solution

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - emergency treatment of hypovolemic shock plasbumin-25 is hyperoncotic and on intravenous infusion will expand the plasma volume by an additional amount, three to four times the volume actually administered, by withdrawing fluid from the interstitial spaces, provided the patient is normally hydrated interstitially or there is interstitial edema.(1) if the patient is dehydrated, additional crystalloids must be given,(4) or alternatively, albumin (human) 5%, usp (plasbumin® -5) should be used. the patient’s hemodynamic response should be monitored and the usual precautions against circulatory overload observed. the total dose should not exceed the level of albumin found in the normal individual, i.e., about 2 g per kg body weight in the absence of active bleeding. although plasbumin-5 is to be preferred for the usual volume deficits, plasbumin-25 with appropriate crystalloids may offer therapeutic advantages in oncotic deficits or in long-standing shock where treatment has been delayed.(2) removal of ascitic flu

PLASMANATE (plasma protein fraction- human solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

plasmanate (plasma protein fraction- human solution

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 2.5 g in 50 ml - treatment of shock — plasmanate is indicated in the treatment of shock due to burns, crushing injuries, abdominal emergencies, and any other cause where there is a predominant loss of plasma fluids and not red blood cells. it is also effective in the emergency treatment of shock due to hemorrhage.(3,4) following the emergency phase of therapy, blood transfusions may be indicated depending on the severity of the blood loss. in infants and small children, plasmanate has been found to be very useful in the initial therapy of shock due to dehydration and infection. plasmanate is contraindicated for use in patients on cardiopulmonary bypass. severe hypotension has been reported in such patients when given plasma protein fraction.(4) plasma protein fraction is contraindicated in patients with severe anemia, congestive heart failure, or increased blood volume.

ALBUREX 20 AU Human Albumin 200 g/L (20% w/v) 100 mL solution for intravenous infusion vial Australia - angielski - Department of Health (Therapeutic Goods Administration)

alburex 20 au human albumin 200 g/l (20% w/v) 100 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 20 g - injection, intravenous infusion - excipient ingredients: sodium octanoate; water for injections; sodium chloride; sodium acetyltryptophanate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUREX 20 AU Human Albumin 200 g/L (20% w/v) 50 mL solution for intravenous infusion vial Australia - angielski - Department of Health (Therapeutic Goods Administration)

alburex 20 au human albumin 200 g/l (20% w/v) 50 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 10 g - injection, intravenous infusion - excipient ingredients: sodium acetyltryptophanate; sodium octanoate; sodium chloride; water for injections - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 500 mL solution for intravenous infusion vial Australia - angielski - Department of Health (Therapeutic Goods Administration)

alburex 5 au human albumin 50 g/l (5% w/v) 500 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 25 g - injection, intravenous infusion - excipient ingredients: water for injections; sodium acetyltryptophanate; sodium chloride; sodium octanoate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial Australia - angielski - Department of Health (Therapeutic Goods Administration)

alburex 5 au human albumin 50 g/l (5% w/v) 250 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 12.5 g - injection, intravenous infusion - excipient ingredients: sodium acetyltryptophanate; sodium octanoate; water for injections; sodium chloride - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

FLEXBUMIN 20% ALBUMIN (HUMAN) USP20% SOLUTION Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

flexbumin 20% albumin (human) usp20% solution

takeda malaysia sdn bhd - albumin (human), usp -

FLEXBUMIN 25% ALBUMIN (HUMAN) USP 25% SOLUTION Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

flexbumin 25% albumin (human) usp 25% solution

takeda malaysia sdn bhd - albumin (human), usp -

HUMAN ALBUMIN 200 g/l Solution for Infusion Irlandia - angielski - HPRA (Health Products Regulatory Authority)

human albumin 200 g/l solution for infusion

baxter healthcare limited - plasma protein containing at least 95% human albumin - solution for infusion - 200 g/l

HUMAN ALBUMIN 50 g/l Solution for Infusion Irlandia - angielski - HPRA (Health Products Regulatory Authority)

human albumin 50 g/l solution for infusion

baxter healthcare limited - plasma protein containing at least 95% human albumin - solution for infusion - 50 g/l